AKS - Healthcare dominates premarket gainers December, 03 2019 09:27 AM AK Steel Holding Corporation Audentes Therapeutics (NASDAQ:BOLD) +105% as Astellas Pharma to buy Audentes Therapeutics for $60/share.More news on: Audentes Therapeutics, Inc., ViewRay, Inc., uniQure N.V., Stocks on the move, Read more ...